Cargando…
Exon Expression Arrays as a Tool to Identify New Cancer Genes
BACKGROUND: Identification of genes that are causally implicated in oncogenesis is a major goal in cancer research. An estimated 10–20% of cancer-related gene mutations result in skipping of one or more exons in the encoded transcripts. Here we report on a strategy to screen in a global fashion for...
Autores principales: | Schutte, Mieke, Elstrodt, Fons, Bralten, Linda B. C., Nagel, Jord H. A., Duijm, Elza, Hollestelle, Antoinette, Vuerhard, Maartje J., Wasielewski, Marijke, Peeters, Justine K., van der Spek, Peter, Sillevis Smitt, Peter A., French, Pim J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2500185/ https://www.ncbi.nlm.nih.gov/pubmed/18688287 http://dx.doi.org/10.1371/journal.pone.0003007 |
Ejemplares similares
-
Low-risk susceptibility alleles in 40 human breast cancer cell lines
por: Riaz, Muhammad, et al.
Publicado: (2009) -
Absence of Common Somatic Alterations in Genes on 1p and 19q in Oligodendrogliomas
por: Bralten, Linda B., et al.
Publicado: (2011) -
Immunotherapy in Glioblastoma: Current Shortcomings and Future Perspectives
por: Weenink, Bas, et al.
Publicado: (2020) -
Tumor-specific mutations in low-frequency genes affect their functional properties
por: Erdem-Eraslan, Lale, et al.
Publicado: (2015) -
Lack of B and T cell reactivity towards IDH1(R132H) in blood and tumor tissue from LGG patients
por: Weenink, Bas, et al.
Publicado: (2019)